Cargando…

Clinical significance of CD38 and CD101 expression in PD-1(+)CD8(+) T cells in patients with epithelial ovarian cancer

Previous studies using mouse liver tumor models have indicated that coexpression of CD38 and CD101 in programmed cell death-1 (PD-1)(+)CD8(+) T cells may reflect fixed dysregulation of CD8(+) T cells and thus indicate a poor response to anti-PD-1 immunotherapy. However, whether CD38 and CD101 expres...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Jian, Wang, Wenting, Liang, Zhiqing, Ni, Bing, He, Wei, Wang, Dan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7285834/
https://www.ncbi.nlm.nih.gov/pubmed/32565998
http://dx.doi.org/10.3892/ol.2020.11580
_version_ 1783544774075088896
author Zhou, Jian
Wang, Wenting
Liang, Zhiqing
Ni, Bing
He, Wei
Wang, Dan
author_facet Zhou, Jian
Wang, Wenting
Liang, Zhiqing
Ni, Bing
He, Wei
Wang, Dan
author_sort Zhou, Jian
collection PubMed
description Previous studies using mouse liver tumor models have indicated that coexpression of CD38 and CD101 in programmed cell death-1 (PD-1)(+)CD8(+) T cells may reflect fixed dysregulation of CD8(+) T cells and thus indicate a poor response to anti-PD-1 immunotherapy. However, whether CD38 and CD101 expression in PD-1(+)CD8(+) T cells can predict the clinical status and efficacy of chemotherapy for various cancer types, including ovarian cancer (OC), remains unclear. In the present study, peripheral blood mononuclear cells (PBMCs) were obtained by Ficoll-Hypaque gradient centrifugation from 96 fresh samples from healthy adult volunteers and patients with epithelial OC, aged 55.21±9.91 years. Additionally, tumor-infiltrating lymphocytes (TILs) were separated using a combination of mechanical, chemical and enzymatic digestion from fresh surgically removed tumor tissues from 15 patients with epithelial OC. The expression of CD38 and CD101 in PD-1(+)CD8(+) T cells or TILs was detected by flow cytometry or immunofluorescence (IF) staining, respectively. The association between the level of CD38/CD101 expression and clinicopathological parameters or postoperative chemotherapy in patients with OC was statistically analyzed. The levels of CD38/CD101-coexpressing PD-1(+)CD8(+) T cells were significantly increased in PBMCs and TILs of patients with OC compared with those of healthy volunteers. The frequency of PD-1(+)CD38(+)CD101(+)CD8(+) T cells among the total PD-1(+)CD8(+) T cell subpopulation was negatively associated with clinical stage, lymph node metastasis and postoperative chemotherapy prognosis in patients with OC. Furthermore, IF staining confirmed colocalization of CD38 and CD101 on the majority of TILs in OC tissues. Thus, the present study suggests that coexpression of CD38 and CD101 in peripheral PD-1(+)CD8(+) T cells and TILs may serve as a new indicator for diagnosis and treatment efficacy in patients with epithelial OC.
format Online
Article
Text
id pubmed-7285834
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-72858342020-06-18 Clinical significance of CD38 and CD101 expression in PD-1(+)CD8(+) T cells in patients with epithelial ovarian cancer Zhou, Jian Wang, Wenting Liang, Zhiqing Ni, Bing He, Wei Wang, Dan Oncol Lett Articles Previous studies using mouse liver tumor models have indicated that coexpression of CD38 and CD101 in programmed cell death-1 (PD-1)(+)CD8(+) T cells may reflect fixed dysregulation of CD8(+) T cells and thus indicate a poor response to anti-PD-1 immunotherapy. However, whether CD38 and CD101 expression in PD-1(+)CD8(+) T cells can predict the clinical status and efficacy of chemotherapy for various cancer types, including ovarian cancer (OC), remains unclear. In the present study, peripheral blood mononuclear cells (PBMCs) were obtained by Ficoll-Hypaque gradient centrifugation from 96 fresh samples from healthy adult volunteers and patients with epithelial OC, aged 55.21±9.91 years. Additionally, tumor-infiltrating lymphocytes (TILs) were separated using a combination of mechanical, chemical and enzymatic digestion from fresh surgically removed tumor tissues from 15 patients with epithelial OC. The expression of CD38 and CD101 in PD-1(+)CD8(+) T cells or TILs was detected by flow cytometry or immunofluorescence (IF) staining, respectively. The association between the level of CD38/CD101 expression and clinicopathological parameters or postoperative chemotherapy in patients with OC was statistically analyzed. The levels of CD38/CD101-coexpressing PD-1(+)CD8(+) T cells were significantly increased in PBMCs and TILs of patients with OC compared with those of healthy volunteers. The frequency of PD-1(+)CD38(+)CD101(+)CD8(+) T cells among the total PD-1(+)CD8(+) T cell subpopulation was negatively associated with clinical stage, lymph node metastasis and postoperative chemotherapy prognosis in patients with OC. Furthermore, IF staining confirmed colocalization of CD38 and CD101 on the majority of TILs in OC tissues. Thus, the present study suggests that coexpression of CD38 and CD101 in peripheral PD-1(+)CD8(+) T cells and TILs may serve as a new indicator for diagnosis and treatment efficacy in patients with epithelial OC. D.A. Spandidos 2020-07 2020-04-28 /pmc/articles/PMC7285834/ /pubmed/32565998 http://dx.doi.org/10.3892/ol.2020.11580 Text en Copyright: © Zhou et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Zhou, Jian
Wang, Wenting
Liang, Zhiqing
Ni, Bing
He, Wei
Wang, Dan
Clinical significance of CD38 and CD101 expression in PD-1(+)CD8(+) T cells in patients with epithelial ovarian cancer
title Clinical significance of CD38 and CD101 expression in PD-1(+)CD8(+) T cells in patients with epithelial ovarian cancer
title_full Clinical significance of CD38 and CD101 expression in PD-1(+)CD8(+) T cells in patients with epithelial ovarian cancer
title_fullStr Clinical significance of CD38 and CD101 expression in PD-1(+)CD8(+) T cells in patients with epithelial ovarian cancer
title_full_unstemmed Clinical significance of CD38 and CD101 expression in PD-1(+)CD8(+) T cells in patients with epithelial ovarian cancer
title_short Clinical significance of CD38 and CD101 expression in PD-1(+)CD8(+) T cells in patients with epithelial ovarian cancer
title_sort clinical significance of cd38 and cd101 expression in pd-1(+)cd8(+) t cells in patients with epithelial ovarian cancer
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7285834/
https://www.ncbi.nlm.nih.gov/pubmed/32565998
http://dx.doi.org/10.3892/ol.2020.11580
work_keys_str_mv AT zhoujian clinicalsignificanceofcd38andcd101expressioninpd1cd8tcellsinpatientswithepithelialovariancancer
AT wangwenting clinicalsignificanceofcd38andcd101expressioninpd1cd8tcellsinpatientswithepithelialovariancancer
AT liangzhiqing clinicalsignificanceofcd38andcd101expressioninpd1cd8tcellsinpatientswithepithelialovariancancer
AT nibing clinicalsignificanceofcd38andcd101expressioninpd1cd8tcellsinpatientswithepithelialovariancancer
AT hewei clinicalsignificanceofcd38andcd101expressioninpd1cd8tcellsinpatientswithepithelialovariancancer
AT wangdan clinicalsignificanceofcd38andcd101expressioninpd1cd8tcellsinpatientswithepithelialovariancancer